Author: Julie Steele

Colin Hill is the president, chairman and co-founder of GNSHealthcare. He brings years of hands-on scientific experience to hisrole, with expertise in the areas of computational physics and systemsbiology.Colin is a frequent speaker at international scientific and industryconferences and has appeared in numerous publications and televisionsegments including The Wall Street Journal, CNBC Morning Call, Nature, Forbes, Wired, and The Economist. He serves as CEO and Chairman of GNSHealthcare”s parent company Via Science, and chairman of the board ofFina Technologies, a subsidiary of Via Science that appliesnext-generation artificial intelligence technology to real-timefinancial trading. He also serves on the board of directors of AesRx, a biopharmaceutical company dedicated to the development of a newtreatment for sickle cell disease.In 2004, Colin was named to MIT Technology Review”s TR100 list of thetop innovators in the world under the age of 35. He graduated fromVirginia Tech with a degree in physics and earned master”s degrees inphysics from McGill University and Cornell University.